CIB2

CIB2 is a calcium- and magnesium-binding EF-hand protein that functions as an essential auxiliary subunit of the TMC1/TMC2 mechanotransduction channel in cochlear hair cells and regulates mTORC1 signaling through direct binding to Rheb GTPase. CIB2 binds TMC1/2 through a conserved hydrophobic groove structurally analogous to the KChIP–Kv4 channel interaction, regulating TMC1/2 localization and stabilizing the channel complex; loss of CIB2 completely abolishes mechanoelectrical transduction currents in auditory (but not vestibular) hair cells and leads to stereocilia degeneration and deafness (PMID:28663585, PMID:34089643, PMID:39773557). CIB2 preferentially binds Mg²⁺ over Ca²⁺ under physiological conditions via its EF3/EF4 motifs, and deafness-causing mutations such as E64D disrupt long-range allosteric communication required for Mg²⁺-dependent conformational switching (PMID:30174586). Mutations in CIB2 cause nonsyndromic deafness DFNB48 and Usher syndrome type 1J (PMID:23023331); independently, CIB2 negatively regulates mTORC1 by sequestering GDP-loaded Rheb, and its loss causes impaired autophagy and age-related macular degeneration-like pathology, while CIB2 also suppresses sphingosine kinase 1 oncogenic signaling by blocking SK1 plasma membrane translocation (PMID:34162842, PMID:28729416).

1. 2008 Medium

   Establishing that CIB2 is a calcium-binding protein with integrin-binding capacity in muscle provided the first molecular identity for CIB2 as a signaling adaptor at cell-matrix junctions.

   Evidence Co-immunoprecipitation, colocalization with integrin α7B at sarcolemma in skeletal muscle

   PMID:18611855

   Open questions at the time

   • Functional consequence of CIB2-integrin interaction in vivo not determined
   • Whether integrin binding is relevant outside muscle tissue unknown
2. 2009 Medium

   Demonstrating CIB2 undergoes N-myristoylation, binds Ca²⁺ with a conformational switch, and is induced by NMDA receptor stimulation in neurons expanded CIB2's functional context beyond muscle.

   Evidence Ca²⁺ binding assays, myristoylation assay, neuronal stimulation with pharmacological inhibitors in hippocampal neurons

   PMID:19433056

   Open questions at the time

   • Neuronal function of CIB2 remains uncharacterized
   • Whether Ca²⁺-induced conformational change is physiologically relevant versus Mg²⁺ binding was unresolved
3. 2012 High

   Identifying CIB2 mutations as causal for DFNB48 deafness and Usher syndrome type 1J, combined with stereocilia localization, established CIB2 as a mechanosensory protein critical for auditory function.

   Evidence Genetic mapping in human families, zebrafish and Drosophila loss-of-function, immunostaining in hair cell stereocilia

   PMID:23023331

   Open questions at the time

   • Molecular mechanism of CIB2 in mechanotransduction unknown
   • Whether CIB2 directly interacts with channel components not yet tested
4. 2017 High

   Three independent studies using CIB2 knockout mice demonstrated that CIB2 is absolutely required for mechanoelectrical transduction currents in cochlear but not vestibular hair cells, and one study identified direct binding to TMC1/TMC2 disrupted by deafness mutations, pinpointing CIB2's mechanistic role at the transduction channel.

   Evidence Mouse KO and knockin, patch-clamp MET current recording, co-immunoprecipitation of CIB2 with TMC1/TMC2, stereocilia morphology analysis

   PMID:28663585 PMID:29084757 PMID:29255404

   Open questions at the time

   • Structural basis of CIB2-TMC interaction unknown
   • Why vestibular hair cells are spared is unexplained
   • Whether CIB2 regulates TMC channel gating or only localization unclear
5. 2017 Medium

   Demonstrating that CIB2 binds sphingosine kinase 1 and blocks its membrane translocation revealed a non-auditory tumor-suppressive function operating through competition with CIB1.

   Evidence Co-immunoprecipitation, SK1 translocation assay, in vivo xenograft tumor growth assays in ovarian cancer cells

   PMID:28729416

   Open questions at the time

   • Whether SK1 regulation is relevant in non-cancer contexts unknown
   • Structural basis of CIB2-SK1 binding not determined
6. 2018 High

   NMR and biophysical analysis resolved the longstanding question of CIB2's preferred cation by showing it binds Mg²⁺ with ~1.7-fold higher affinity than Ca²⁺, establishing CIB2 as likely Mg²⁺-bound in vivo, and revealing that the USH1J E64D mutation disrupts allosteric communication between the N-terminus and EF3 cation-binding site.

   Evidence NMR spectroscopy, isothermal titration calorimetry, analytical ultracentrifugation, site-directed mutagenesis

   PMID:30174586

   Open questions at the time

   • Whether Mg²⁺ vs Ca²⁺ occupancy modulates TMC binding was not tested
   • No full-length CIB2 structure in complex with a physiological partner
7. 2021 High

   Crystal structures of CIB2/CIB3 and the CIB3–TMC1 co-crystal revealed that CIB proteins bind TMC1/2 through a hydrophobic groove analogous to KChIP–Kv4 interactions, establishing CIB2 as a bona fide auxiliary channel subunit that regulates TMC localization and function.

   Evidence X-ray crystallography, co-crystal structure of CIB3 with TMC1 cytoplasmic domain, CIB2/CIB3 functional rescue in KO mice

   PMID:34089643

   Open questions at the time

   • Full-length TMC–CIB complex structure not available
   • How CIB2 regulates channel gating at the biophysical level remains unclear
8. 2021 High

   Discovery that CIB2 binds GDP-loaded Rheb and negatively regulates mTORC1 revealed an entirely distinct signaling axis; CIB2 deficiency causes impaired autophagy, reduced lysosomal capacity, and AMD-like retinal pathology.

   Evidence Co-immunoprecipitation of CIB2 with GDP-Rheb, mTORC1 signaling and autophagy flux assays in KO mice, overexpression rescue in LAM patient fibroblasts

   PMID:34162842

   Open questions at the time

   • Whether mTORC1 dysregulation contributes to deafness phenotype unknown
   • Structural basis of CIB2-Rheb interaction not determined
   • Relative importance of mTORC1 versus TMC pathway in retinal disease unresolved
9. 2025 High

   AlphaFold2 modeling validated by NMR showed CIB proteins simultaneously contact at least two cytoplasmic domains of TMC1/2, and molecular dynamics simulations predicted CIB binding structurally stabilizes TMC channels to form functional cation channels, providing a mechanistic explanation for why CIB2 loss abolishes transduction.

   Evidence AlphaFold2 structural prediction, NMR validation, molecular dynamics simulations, mouse and zebrafish KO electrophysiology

   PMID:39773557

   Open questions at the time

   • Experimentally determined full-length TMC–CIB complex structure still lacking
   • Whether CIB2 modulates ion selectivity or conductance properties directly not resolved

• Key open questions include how CIB2's dual roles in mechanotransduction and mTORC1 regulation are coordinated in tissues where both pathways are active (e.g., retina), and the structural and biophysical basis of CIB2-mediated TMC channel gating.
• No experimentally determined full-length TMC–CIB complex structure
• Relationship between Mg²⁺/Ca²⁺ binding state and TMC channel regulation untested
• Tissue-specific coordination of TMC and Rheb-mTORC1 functions unresolved